Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Kushner

Showing results (211-220 of 245) with videos related to

Pageof 25
Sort By:
EMBO Reports|December 3, 2019
Loss of ANCO1 repression at AIB1/YAP targets drives breast cancer progressionMax H Kushner, Virginie Ory, Garrett T Graham, et al.
JCO Precision Oncology|July 12, 2021
Differential Impact of <i>ALK</i> Mutations in NeuroblastomaTara O'Donohue, Nitya Gulati, Audrey Mauguen, et al.
Frontiers in Oncology|January 23, 2023
Skeletal muscle metastases in neuroblastoma share common progenitors with primary tumor and biologically resemble stage MS diseaseChristina Fong, Brian H Kushner, Angela Di Giannatale, et al.
Oncotarget|December 2, 2015
Lack of survival advantage with autologous stem-cell transplantation in high-risk neuroblastoma consolidated by anti-GD2 immunotherapy and isotretinoinBrian H Kushner, Irina Ostrovnaya, Irene Y Cheung, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 17, 1998
Anti-G(D2) antibody treatment of minimal residual stage 4 neuroblastoma diagnosed at more than 1 year of ageN K Cheung, B H Kushner, I Y Cheung, et al.
Cold Spring Harbor Molecular Case Studies|June 29, 2017
Germline <i>BRCA2</i> mutations detected in pediatric sequencing studies impact parents' evaluation and careMichael F Walsh, Jennifer Kennedy, Megan Harlan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 1995
Very-high-dose short-term chemotherapy for poor-risk peripheral primitive neuroectodermal tumors, including Ewing's sarcoma, in children and young adultsB H Kushner, P A Meyers, W L Gerald, et al.
Journal of Pediatric Surgery|December 15, 2015
Salvage rates after progression of high-risk neuroblastoma with a soft tissue massJennifer M Murphy, Irene-Isabel P Lim, Benjamin A Farber, et al.
Pediatric Blood & Cancer|February 17, 2005
Long-term complications in survivors of advanced stage neuroblastomaCaroline Laverdière, Nai-Kong V Cheung, Brian H Kushner, et al.
International Journal of Cancer|March 26, 2018
Treatment and outcome of adult-onset neuroblastomaMaya Suzuki, Brian H Kushner, Kim Kramer, et al.
Pageof 25

Showing results (211-220 of 245) with videos related to

Sort By:
Pageof 25
EMBO Reports|December 3, 2019
Loss of ANCO1 repression at AIB1/YAP targets drives breast cancer progressionMax H Kushner, Virginie Ory, Garrett T Graham, et al.
JCO Precision Oncology|July 12, 2021
Differential Impact of <i>ALK</i> Mutations in NeuroblastomaTara O'Donohue, Nitya Gulati, Audrey Mauguen, et al.
Frontiers in Oncology|January 23, 2023
Skeletal muscle metastases in neuroblastoma share common progenitors with primary tumor and biologically resemble stage MS diseaseChristina Fong, Brian H Kushner, Angela Di Giannatale, et al.
Oncotarget|December 2, 2015
Lack of survival advantage with autologous stem-cell transplantation in high-risk neuroblastoma consolidated by anti-GD2 immunotherapy and isotretinoinBrian H Kushner, Irina Ostrovnaya, Irene Y Cheung, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 17, 1998
Anti-G(D2) antibody treatment of minimal residual stage 4 neuroblastoma diagnosed at more than 1 year of ageN K Cheung, B H Kushner, I Y Cheung, et al.
Cold Spring Harbor Molecular Case Studies|June 29, 2017
Germline <i>BRCA2</i> mutations detected in pediatric sequencing studies impact parents' evaluation and careMichael F Walsh, Jennifer Kennedy, Megan Harlan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 1995
Very-high-dose short-term chemotherapy for poor-risk peripheral primitive neuroectodermal tumors, including Ewing's sarcoma, in children and young adultsB H Kushner, P A Meyers, W L Gerald, et al.
Journal of Pediatric Surgery|December 15, 2015
Salvage rates after progression of high-risk neuroblastoma with a soft tissue massJennifer M Murphy, Irene-Isabel P Lim, Benjamin A Farber, et al.
Pediatric Blood & Cancer|February 17, 2005
Long-term complications in survivors of advanced stage neuroblastomaCaroline Laverdière, Nai-Kong V Cheung, Brian H Kushner, et al.
International Journal of Cancer|March 26, 2018
Treatment and outcome of adult-onset neuroblastomaMaya Suzuki, Brian H Kushner, Kim Kramer, et al.
Pageof 25